275 related articles for article (PubMed ID: 18416817)
1. ATBF1 and NQO1 as candidate targets for allelic loss at chromosome arm 16q in breast cancer: absence of somatic ATBF1 mutations and no role for the C609T NQO1 polymorphism.
Cleton-Jansen AM; van Eijk R; Lombaerts M; Schmidt MK; Van't Veer LJ; Philippo K; Zimmerman RM; Peterse JL; Smit VT; van Wezel T; Cornelisse CJ
BMC Cancer; 2008 Apr; 8():105. PubMed ID: 18416817
[TBL] [Abstract][Full Text] [Related]
2. Loss of heterozygosity at the ATBF1-A locus located in the 16q22 minimal region in breast cancer.
Kai K; Zhang Z; Yamashita H; Yamamoto Y; Miura Y; Iwase H
BMC Cancer; 2008 Sep; 8():262. PubMed ID: 18796146
[TBL] [Abstract][Full Text] [Related]
3. Infrequent mutation of ATBF1 in human breast cancer.
Sun X; Zhou Y; Otto KB; Wang M; Chen C; Zhou W; Subramanian K; Vertino PM; Dong JT
J Cancer Res Clin Oncol; 2007 Feb; 133(2):103-5. PubMed ID: 16932943
[TBL] [Abstract][Full Text] [Related]
4. Loss of heterozygosity mapping at chromosome arm 16q in 712 breast tumors reveals factors that influence delineation of candidate regions.
Cleton-Jansen AM; Callen DF; Seshadri R; Goldup S; Mccallum B; Crawford J; Powell JA; Settasatian C; van Beerendonk H; Moerland EW; Smit VT; Harris WH; Millis R; Morgan NV; Barnes D; Mathew CG; Cornelisse CJ
Cancer Res; 2001 Feb; 61(3):1171-7. PubMed ID: 11221848
[TBL] [Abstract][Full Text] [Related]
5. Influence of whole arm loss of chromosome 16q on gene expression patterns in oestrogen receptor-positive, invasive breast cancer.
Hungermann D; Schmidt H; Natrajan R; Tidow N; Poos K; Reis-Filho JS; Brandt B; Buerger H; Korsching E
J Pathol; 2011 Aug; 224(4):517-28. PubMed ID: 21706489
[TBL] [Abstract][Full Text] [Related]
6. Involvement of ATM missense variants and mutations in a series of unselected breast cancer cases.
Rodriguez C; Vallès H; Causse A; Johannsdottir V; Eliaou JF; Theillet C
Genes Chromosomes Cancer; 2002 Feb; 33(2):141-9. PubMed ID: 11793440
[TBL] [Abstract][Full Text] [Related]
7. At least two different regions are involved in allelic imbalance on chromosome arm 16q in breast cancer.
Cleton-Jansen AM; Moerland EW; Kuipers-Dijkshoorn NJ; Callen DF; Sutherland GR; Hansen B; Devilee P; Cornelisse CJ
Genes Chromosomes Cancer; 1994 Feb; 9(2):101-7. PubMed ID: 7513539
[TBL] [Abstract][Full Text] [Related]
8. Expression analysis of candidate breast tumour suppressor genes on chromosome 16q.
van Wezel T; Lombaerts M; van Roon EH; Philippo K; Baelde HJ; Szuhai K; Cornelisse CJ; Cleton-Jansen AM
Breast Cancer Res; 2005; 7(6):R998-1004. PubMed ID: 16280054
[TBL] [Abstract][Full Text] [Related]
9. Are there any more ovarian tumor suppressor genes? A new perspective using ultra high-resolution copy number and loss of heterozygosity analysis.
Gorringe KL; Ramakrishna M; Williams LH; Sridhar A; Boyle SE; Bearfoot JL; Li J; Anglesio MS; Campbell IG
Genes Chromosomes Cancer; 2009 Oct; 48(10):931-42. PubMed ID: 19603523
[TBL] [Abstract][Full Text] [Related]
10. Allelic imbalance study of 16q in human primary breast carcinomas using microsatellite markers.
Dorion-Bonnet F; Mautalen S; Hostein I; Longy M
Genes Chromosomes Cancer; 1995 Nov; 14(3):171-81. PubMed ID: 8589033
[TBL] [Abstract][Full Text] [Related]
11. Fine mapping of Wilms' tumors with 16q loss of heterozygosity localizes the putative tumor suppressor gene to a region of 6.7 megabases.
Safford SD; Goyeau D; Freemerman AJ; Bentley R; Everett ML; Grundy PE; Skinner MA
Ann Surg Oncol; 2003 Mar; 10(2):136-43. PubMed ID: 12620908
[TBL] [Abstract][Full Text] [Related]
12. Loss of heterozygosity at chromosome 16q in prostate adenocarcinoma: identification of three independent regions.
Latil A; Cussenot O; Fournier G; Driouch K; Lidereau R
Cancer Res; 1997 Mar; 57(6):1058-62. PubMed ID: 9067271
[TBL] [Abstract][Full Text] [Related]
13. Frequent somatic mutations of the transcription factor ATBF1 in human prostate cancer.
Sun X; Frierson HF; Chen C; Li C; Ran Q; Otto KB; Cantarel BL; Vessella RL; Gao AC; Petros J; Miura Y; Simons JW; Dong JT
Nat Genet; 2005 Apr; 37(4):407-12. PubMed ID: 15750593
[TBL] [Abstract][Full Text] [Related]
14. Chromosome arm 16q in Wilms tumors: unbalanced chromosomal translocations, loss of heterozygosity, and assessment of the CTCF gene.
Yeh A; Wei M; Golub SB; Yamashiro DJ; Murty VV; Tycko B
Genes Chromosomes Cancer; 2002 Oct; 35(2):156-63. PubMed ID: 12203779
[TBL] [Abstract][Full Text] [Related]
15. Different mechanisms of chromosome 16 loss of heterozygosity in well- versus poorly differentiated ductal breast cancer.
Cleton-Jansen AM; Buerger H; Haar Nt; Philippo K; van de Vijver MJ; Boecker W; Smit VT; Cornelisse CJ
Genes Chromosomes Cancer; 2004 Oct; 41(2):109-16. PubMed ID: 15287023
[TBL] [Abstract][Full Text] [Related]
16. Loss of heterozygosity on chromosome arm 16q in breast cancer metastases.
Driouch K; Dorion-Bonnet F; Briffod M; Champéme MH; Longy M; Lidereau R
Genes Chromosomes Cancer; 1997 Jul; 19(3):185-91. PubMed ID: 9219000
[TBL] [Abstract][Full Text] [Related]
17. Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis.
Clifford SC; Prowse AH; Affara NA; Buys CH; Maher ER
Genes Chromosomes Cancer; 1998 Jul; 22(3):200-9. PubMed ID: 9624531
[TBL] [Abstract][Full Text] [Related]
18. A widely expressed transcription factor with multiple DNA sequence specificity, CTCF, is localized at chromosome segment 16q22.1 within one of the smallest regions of overlap for common deletions in breast and prostate cancers.
Filippova GN; Lindblom A; Meincke LJ; Klenova EM; Neiman PE; Collins SJ; Doggett NA; Lobanenkov VV
Genes Chromosomes Cancer; 1998 May; 22(1):26-36. PubMed ID: 9591631
[TBL] [Abstract][Full Text] [Related]
19. Identification of a candidate tumor suppressor gene RHOBTB1 located at a novel allelic loss region 10q21 in head and neck cancer.
Beder LB; Gunduz M; Ouchida M; Gunduz E; Sakai A; Fukushima K; Nagatsuka H; Ito S; Honjo N; Nishizaki K; Shimizu K
J Cancer Res Clin Oncol; 2006 Jan; 132(1):19-27. PubMed ID: 16170569
[TBL] [Abstract][Full Text] [Related]
20. Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations.
Cornelis RS; van Vliet M; Vos CB; Cleton-Jansen AM; van de Vijver MJ; Peterse JL; Khan PM; Børresen AL; Cornelisse CJ; Devilee P
Cancer Res; 1994 Aug; 54(15):4200-6. PubMed ID: 8033152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
